Showing 9,281 - 9,300 results of 102,930 for search '(( 50 ((teer decrease) OR (mean decrease)) ) OR ( 5 ((point decrease) OR (a decrease)) ))', query time: 1.54s Refine Results
  1. 9281

    Genes in extracellular clusters E1-5. by Gareth A. Cromie (17118013)

    Published 2024
    “…Here, we examine colony development in a yeast strain (F13) that produces colonies with a highly structured “ruffled” phenotype in the colony periphery and an unstructured “smooth” phenotype in the colony center. …”
  2. 9282
  3. 9283

    Characteristics of HACE respondents by year. by David Henderson (4612354)

    Published 2025
    “…</p><p>Conclusion</p><p>Satisfaction overall, and with access to GP consultations, steadily declined between 2011/12 and 2021/22, with a more pronounced decrease following the COVID-19 pandemic, particularly among the most deprived and complex patients. …”
  4. 9284
  5. 9285

    Preconditioning anti-VEGF antibody decreased IR-induced pulmonary edema and microvascular hyper-permeability. by Chou-Chin Lan (2938674)

    Published 2016
    “…<p><b>(A)</b> Lung weight (LW) and wet/dry weight (W/D) was significantly increased in the IR group (p<0.05) and decreased in the B5-IR (p<0.05). …”
  6. 9286
  7. 9287
  8. 9288
  9. 9289
  10. 9290
  11. 9291

    Preconditioning anti-VEGF antibody decreased total protein concentration and pro-inflammatory cytokines in BALF. by Chou-Chin Lan (2938674)

    Published 2016
    “…Preconditioning anti-VEGF antibody (5 mg/kg) decreased IR-induced total protein concentration and TNF-α in BALF (both <i>p</i><0.05). …”
  12. 9292

    Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice by Michael T Buckley (37161)

    Published 2011
    “…Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”
  13. 9293
  14. 9294
  15. 9295
  16. 9296
  17. 9297
  18. 9298
  19. 9299
  20. 9300

    <i>DAPK1</i> Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis by Antonella Agodi (638417)

    Published 2015
    “…The aim of the present study was to carry out a systematic review and a meta-analysis in order to evaluate <i>DAPK1</i> promoter methylation as an epigenetic marker for CC risk.…”